TORONTO, ON--(Marketwired - March 20, 2017) - During an informative session on Wednesday, April 5, 2016, industry experts from Fisher BioServices, Kristen Franklin, Client Services Manager and Amy Hendricks, Project Manager will review some of the key components to consider when developing a strategy to minimize risk, manage cost, and ultimately deliver a product to market. The success of developing a cellular therapy rests on the ability to deliver a viable, potent product. This positive end-result is directly attributable to the strategy in place and the supporting processes. A reliable cell therapy development strategy is imperative to ensuring your therapeutic materials remain viable from the point of collection, through manufacture, to the final clinical site delivery. Key Learning Objectives: For more information or to register for this complimentary event, visit: Cell Therapy - Achieving Success on the Road to Commercialization Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks … Continue reading →

Runner's World Stem Cell Therapy | Runner's World Runner's World They're harvested and then injected into an injured area to stimulate tissue healing. Has stem cell therapy helped the Boden's poster girl say her first words? Cerebral palsy patient Holly, 11, shows ...Daily Mail $145.8 Million Stem Cell Therapy Market by Type, Therapeutic Application, Cell Source - Global Forecasts to 2021 ...Business Wire (press release) all 19 news articles » Read the original post: Stem Cell Therapy | Runner's World - Runner's World … Continue reading →

Masayo Takahashi (second from left) treated macular degeneration with retinal tissue grown from iPS cells. Kyodo News/Contributor/getty images By Dennis NormileMar. 15, 2017 , 5:00 PM Its official: The first use of induced pluripotent stem (iPS) cells in a human has proved safe, if not clearly effective. Japanese researchers reported in this weeks issue of The New England Journal of Medicine (NEJM) that using the cells to replace eye tissue damaged by age-related macular degeneration (AMD) did not improve a patients vision, but did halt disease progression. They had described the outcome at conferences, but publication of the details is an encouraging milestone for other groups gearing up to treat diseased or damaged organs with the versatile replacement cells, which are derived from mature tissues. This initial success is pretty momentous, says Alan Trounson, a stem cell scientist at the Hudson Institute of Medical Research in Melbourne, Australia. But the broader picture for iPS therapies is mixed, as researchers have retreated from their initial hopes of creating custommade stem cells from each patients tissue. That strategy might have ensured that recipients immune systems would accept the new cells. But it proved too slow and expensive, says Shinya Yamanaka of Kyoto … Continue reading →

A new report published by the New England Journal of Medicine details that three women have become permanently blinded after undergoing stem cell injections into their eyes at a Florida clinic. The three subjects were suffering from macular degeneration, an age-related eye disease that leads to vision impairment, and were under the impression that they were participating in a clinical trial for treatment of the disorder. In reality, these women had undergone the procedure at an unregulated Florida clinic called US Stem Cell, where staffers extracted stem cells from the womens belly fat via liposuction and then injected them into the eyes. Stem cell treatments, although buzzy (youve heard about them in the context of being able to treat a myriad of disorders and even incorporated into skin care products) are largely unregulated, making it difficult for consumers to differentiate between solid medical research versus marketing hype. While there is plenty of legitimate research being done in the spacesome very promisingtherapy centers that lack safety standards or sufficient medical knowledge are commonplace. You May Also Like: What You Need to Know About the New Botox Bill According to Westchester, NY, oculoplastic surgeon James Gordon, MD, stem cell injections could potentially … Continue reading →